This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link. Do Not Sell My Personal Information

In 2017, the Ambulanzpartner Akademie is once again offering exciting seminars for participants in the care network and interested guests. The thematic focus this year is clearly on amyotrophic lateral sclerosis. Since Ambulanzpartner was founded in 2011, over 6,500 people with ALS have been cared for in our network. We would like to share the…

Ambulanzpartner receives research funding from the Federal Ministry of Education and Research (BMBF) for a project on technical care support for people with amyotrophic lateral sclerosis (ALS). In the ROBINA project, five companies are researching a new type of adaptive human-technology interaction concept together with ambulance partners. The aim of the project is to transfer…

Medication management comprises the control and monitoring of the medication process from prescription to administration of the medication. Medication management can be used to identify and rectify application errors, adherence problems or adverse drug events. Cross-professional medication management also includes medical (e.g. diagnoses) and nursing (e.g. care, care level) data. This allows medication to be…
The special consultation for ALS at the Outpatient Clinic of the Neurological University Hospital Halle (Saale) has been a new partner in the OutpatientPartner network since November 2016. Our network currently consists of 2,300 people with amyotrophic lateral sclerosis (ALS) who are treated at the university hospitals in Berlin, Bochum, Dresden, Hanover, Magdeburg, Jena, Rostock…

At the forum of the Federal Association of German Neurologists (BDN) as part of the 89th Congress of the German Society of Neurology on September 23, 2016 in Mannheim, AmbulanzPartner will be presented, among other things. This year’s BDN Forum will focus on new ways of providing participation- and patient-centred medical care as well as…

AmbulanzPartner is featured in the current issue of the specialist journal NeuroTransmitter (1/2016 supplement). NeuroTransmitter sees itself as a discussion forum and leading professional-political medium for neurologists, neurologists and psychiatrists in Germany. As the organ of three professional associations, NeuroTransmitter is a must-read for neurologists and neurologists. Our aim with this article is to provide…
The Clinic for Sleep Medicine and Neuromuscular Diseases at Münster University Hospital is a new partner in the OutpatientPartner network from November 2015. The outpatient clinic is headed by Prof. Dr. Peter Young and Dr. Matthias Boentert. The focus of the work is the outpatient care of patients with amyotrophic lateral sclerosis (ALS) and muscle…
A first scientific evaluation of aggregated care data from the Outpatient Partner Network was published this month in “Der Nervenarzt” – the official publication of the German Society of Neurology (DGN). The publication analyzes data on the provision of assistive devices for patients with amyotrophic lateral sclerosis (ALS) in the period from June 2011 to…

The AmbulanzPartner Akademie is once again offering a number of compact seminars for medical partners and care partners in 2015. This year’s seminars will focus on the modern provision of aids for complex neurological diseases such as amyotrophic lateral sclerosis, Parkinson’s disease and stroke. The seminars serve to improve the care of patients in the…